AI assistant
NovoCure Ltd — Director's Dealing 2017
Mar 9, 2017
31949_dirs_2017-03-09_ed952afb-a906-4ff1-94b2-7a3168992063.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-03-08
Reporting Person: DOYLE WILLIAM F (Director, Executive Chairman, 10% Owner)
Reporting Person: WFD Ventures Fund II, L.P. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-08 | Ordinary Shares | J | 19732767 | — | Disposed | 43000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 84699 | Direct |
| Ordinary Shares | 625954 | Indirect |
Footnotes
F1: On March 8, 2017, WFD Ventures Fund II, L.P. distributed, on a pro-rata basis and without consideration, to its economic partners 19,732,767 of the Issuer's shares, including 625,954 of such shares to WFD-GP II, LLC.
F2: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.